Related Experiment Videos
Peptide interactions with G-protein coupled receptors
1Center for Computational Biology, 700 S. Euclid Avenue, Washington University, St. Louis, MO 63110, USA. garland@gpc.wustl.edu
Biopolymers
|January 5, 2002
Summary
This review explores how G-protein coupled receptors (GPCRs) recognize peptide ligands. Advances in rhodopsin structure and homology modeling aid in understanding peptide binding and G-protein activation mechanisms.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- G-protein coupled receptors (GPCRs) are crucial cell surface receptors involved in numerous physiological processes.
- Understanding peptide ligand recognition by GPCRs is vital for drug discovery and therapeutic development.
- Limited structural data for peptide-binding GPCRs has historically hindered detailed mechanistic studies.
Purpose of the Study:
- To review indirect approaches for determining peptide-bound GPCR conformations.
- To highlight recent advances in GPCR structural biology and their application to peptide recognition.
- To compare peptide ligand binding with non-peptide antagonist interactions.
Main Methods:
- Utilizing rhodopsin crystallography to create homology models of inactive GPCR states.
- Employing GPCR mutagenesis and compound screening for structure-activity relationship studies.
- Comparing peptide recognition motifs with those in other receptor systems.
Main Results:
- Homology modeling based on rhodopsin provides a scaffold for studying diverse peptide-binding GPCRs.
- Structure-activity studies offer experimental validation for proposed binding sites.
- Evidence suggests distinct binding interfaces for peptide ligands (transmembrane-extracellular loop interface) and non-peptide antagonists (within transmembrane segments).
Conclusions:
- Indirect methods, including homology modeling and mutagenesis, are effective for elucidating peptide-GPCR interactions.
- Distinct binding modes exist for peptide ligands and non-peptide antagonists.
- Emerging models are beginning to explain GPCR activation by peptide ligands.